Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: A prospective cohort study

BMC Medical Genetics

Volumn 10, Issue , 2009, Pages 103-

  Gallicchio, Lisa ^a,b   Chang, Howard H ^b   Christo, Dana K ^b   Thuita, Lucy ^b   Huang, Han Y ^b   Strickland, Paul ^b   Ruczinski, Ingo ^b   Clipp, Sandra ^b   Helzlsouer, Kathy J ^a,b  

^a MERCY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; LEPTIN RECEPTOR; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; AGED; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADULT; AGED; BODY MASS INDEX; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 70350437856     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-10-103     Document Type: Article

References (45)

1. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037. 10.1001/jama.298.17.2028, 17986696.
2. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005, 293:1861-1867. 10.1001/jama.293.15.1861, 15840860.
3. Calle EE, Teras LR, Thun MJ. Obesity and mortality. N Engl J Med 2005, 353:2197-2199. 10.1056/NEJM200511173532020, 16291995.
4. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006, 355:763-778. 10.1056/NEJMoa055643, 16926275.
5. Katzmarzyk PT, Janssen I, Ardern CI. Physical inactivity, excess adiposity and premature mortality. Obes Rev 2003, 4:257-290. 10.1046/j.1467-789X.2003.00120.x, 14649376.
6. McGee DL. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005, 15:87-97. 10.1016/j.annepidem.2004.05.012, 15652713.
7. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007, 132:2087-2102. 10.1053/j.gastro.2007.03.052, 17498505.
8. Spiegelman BM, Hu E, Kim JB, Brun R. PPAR gamma and the control of adipogenesis. Biochimie 1997, 79:111-112. 10.1016/S0300-9084(97)81500-3, 9209705.
9. Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 2009, 297:E271-E288. 10.1152/ajpendo.90920.2008, 19318514.
10. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007, 101:545-559. 10.1161/CIRCRESAHA.107.156596, 17872473.
11. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 2009, 46:83-106. 10.1080/10408360802610878, 19255916.
12. Fuemmeler BF, gurs-Collins TD, McClernon FJ, Kollins SH, Kail ME, Bergen AW, shley-Koch AE. Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring) 2008, 16:348-355. 10.1038/oby.2007.65, 18239643.
13. Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev 2007, 29:49-61. 10.1093/epirev/mxm004, 17566051.
14. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B, Perusse L, Bouchard C. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006, 14:529-644. 10.1038/oby.2006.71, 16741264.
15. Genkinger JM, Platz EA, Hoffman SC, Strickland P, Huang HY, Comstock GW, Helzlsouer KJ. C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival. Mech Ageing Dev 2006, 127:371-377. 10.1016/j.mad.2005.12.006, 16458347.
16. Klintschar M, Neuhuber F. Evaluation of an alkaline lysis method for the extraction of DNA from whole blood and forensic stains for STR analysis. J Forensic Sci 2000, 45:669-673.
17. Rubin DB. Inference and missing data. Biometrika 1976, 63:581-592.
18. Kooperberg C, Ruczinski I, LeBlanc ML, Hsu L. Sequence analysis using logic regression. Genetic Epidemiology 2001, 21:S626-S631.
19. Ruczinski I, Kooperberg C, LeBlanc ML. Logic regression. Journal of Computational and Graphical Statistics 2003, 12:475-511.
20. Gallicchio L, Chang H, Christo DK, Thuita L, Huang HY, Strickland P, Ruczinski I, Hoffman SC, Helzlsouer KJ. Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. Am J Epidemiol 2008, 167:807-813. 10.1093/aje/kwm378, 18263601.
21. Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol 2004, 39:629-635. 10.1016/j.exger.2003.11.019, 15050299.
22. Bonafe M, Marchegiani F, Cardelli M, Olivieri F, Cavallone L, Giovagnetti S, Pieri C, Marra M, Antonicelli R, Troiano L. Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet 2002, 10:292-296. 10.1038/sj.ejhg.5200806, 12082503.
23. Marchegiani F, Marra M, Spazzafumo L, James RW, Boemi M, Olivieri F, Cardelli M, Cavallone L, Bonfigli AR, Franceschi C. Paraoxonase activity and genotype predispose to successful aging. J Gerontol A Biol Sci Med Sci 2006, 61:541-546.
24. Christiansen L, Bathum L, Frederiksen H, Christensen K. Paraoxonase 1 polymorphisms and survival. Eur J Hum Genet 2004, 12:843-847. 10.1038/sj.ejhg.5201235, 15241482.
25. Novelli V, Viviani AC, Roncarati R, Guffanti G, Malovini A, Piluso G, Puca AA. Lack of replication of genetic associations with human longevity. Biogerontology 2008, 9:85-92. 10.1007/s10522-007-9116-4, 18034366.
26. Heijmans BT, Westendorp RG, Slagboom PE. Common gene variants, mortality and extreme longevity in humans. Exp Gerontol 2000, 35:865-877. 10.1016/S0531-5565(00)00171-6, 11053677.
27. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998, 423:57-60. 10.1016/S0014-5793(98)00064-7, 9506841.
28. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003, 361:598-604. 10.1016/S0140-6736(03)12520-2, 12598158.
29. Paracchini V, Pedotti P, Taioli E. Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 2005, 162:101-114. 10.1093/aje/kwi174, 15972940.
30. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341. 10.1126/science.1142364, 17463249.
31. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, Berndt SI, Elliott AL, Jackson AU, Lamina C. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009, 41:25-34. 10.1038/ng.287, 2695662, 19079261.
32. Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, Gallina S, Durand E, Vatin V, Degraeve F, Proenca C. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009, 41:157-159. 10.1038/ng.301, 19151714.
33. Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007, 39:724-726. 10.1038/ng2048, 17496892.
34. Hinney A, Nguyen TT, Scherag A, Friedel S, Bronner G, Muller TD, Grallert H, Illig T, Wichmann HE, Rief W. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE 2007, 2:e1361. 10.1371/journal.pone.0001361, 2137937, 18159244.
35. Zimmermann E, Kring SI, Berentzen TL, Holst C, Pers TH, Hansen T, Pedersen O, Sorensen TI, Jess T. Fatness-associated FTO gene variant increases mortality independent of fatness--in cohorts of Danish men. PLoS ONE 2009, 4:e4428. 10.1371/journal.pone.0004428, 2639637, 19214238.
36. Liu YJ, Liu XG, Wang L, Dina C, Yan H, Liu JF, Levy S, Papasian CJ, Drees BM, Hamilton JJ. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet 2008, 17:1803-1813. 10.1093/hmg/ddn072, 18325910.
37. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008, 40:768-775. 10.1038/ng.140, 2669167, 18454148.
38. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, Styrkarsdottir U, Gretarsdottir S, Thorlacius S, Jonsdottir I. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009, 41:18-24. 10.1038/ng.274, 19079260.
39. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 2004, 74:572-581. 10.1086/382490, 1193776, 14973783.
40. Stutzmann F, Vatin V, Cauchi S, Morandi A, Jouret B, Landt O, Tounian P, Levy-Marchal C, Buzzetti R, Pinelli L. Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum Mol Genet 2007, 16:1837-1844. 10.1093/hmg/ddm132, 17519222.
41. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB. A common genetic variant is associated with adult and childhood obesity. Science 2006, 312:279-283. 10.1126/science.1124779, 16614226.
42. Hall DH, Rahman T, Avery PJ, Keavney B. INSIG-2 promoter polymorphism and obesity related phenotypes: association study in 1428 members of 248 families. BMC Med Genet 2006, 7:83. 10.1186/1471-2350-7-83, 1698479, 17137505.
43. Lyon HN, Emilsson V, Hinney A, Heid IM, Lasky-Su J, Zhu X, Thorleifsson G, Gunnarsdottir S, Walters GB, Thorsteinsdottir U. The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet 2007, 3:e61. 10.1371/journal.pgen.0030061, 1857727, 17465681.
44. Mizuta E, Kokubo Y, Yamanaka I, Miyamoto Y, Okayama A, Yoshimasa Y, Tomoike H, Morisaki H, Morisaki T. Leptin gene and leptin receptor gene polymorphisms are associated with sweet preference and obesity. Hypertens Res 2008, 31:1069-1077. 10.1291/hypres.31.1069, 18716353.
45. International Obesity Taskforce About obesity 2005. London, United Kingdom 2005,